SEC FORM 3

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Del Cueto Cuevas Oscar Augusto

(Last)

(First)

(Middle)

KANSAS CITY SOUTHERN

427 W. 12TH STREET

(Street)

KANSAS CITY

64105

(City)

(State)

(Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
08/01/2020

3. Issuer Name and Ticker or Trading Symbol
KANSAS CITY SOUTHERN [ KSU ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
	President & Exec Rep of Sub

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	6,070	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivative Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
Employee Stock Option (Right to Buy)	⁽¹⁾	02/22/2021	Common Stock	1,046	$52.62	D
Employee Stock Option (Right to Buy)	⁽²⁾	02/21/2022	Common Stock	1,167	$66.99	D
Employee Stock Option (Right to Buy)	⁽³⁾	02/20/2023	Common Stock	955	$97.77	D
Employee Stock Option (Right to Buy)	⁽⁴⁾	02/19/2024	Common Stock	1,018	$94.23	D
Employee Stock Option (Right to Buy)	⁽⁵⁾	02/17/2025	Common Stock	976	$119.35	D
Employee Stock Option (Right to Buy)	⁽⁶⁾	02/18/2026	Common Stock	1,316	$82.71	D
Employee Stock Option (Right to Buy)	⁽⁷⁾	02/16/2027	Common Stock	601	$86.89	D
Employee Stock Option (Right to Buy)	⁽⁸⁾	03/05/2028	Common Stock	674	$105.83	D
Employee Stock Option (Right to Buy)	⁽⁹⁾	03/04/2029	Common Stock	894	$110.13	D
Employee Stock Option (Right to Buy)	⁽¹⁰⁾	02/06/2030	Common Stock	738	$171.86	D

Explanation of Responses:

1. These options were granted on February 23, 2011 and became exercisable in two equal annual installments on February 23, 2013 and February 23, 2014.

2. These options were granted on February 22, 2012 and became exercisable in three equal annual installments on February 22, 2013, February 22, 2014, February 22, 2015.

3. These options were granted on February 21, 2013 and became exercisable in three equal annual installments on February 21, 2014, February 21, 2015, February 21, 2016.

4. These options were granted on February 20, 2014 and became exercisable in three equal annual installments on February 20, 2015, February 20, 2016, February 20, 2017.

5. These options were granted on February 18, 2015 and became exercisable in three equal annual installments on February 18, 2016, February 18, 2017, February 18, 2018.

6. These options were granted on February 19, 2016 and became exercisable in three equal annual installments on February 19, 2017, February 19, 2018, February 19, 2019.

7. These options were granted on February 17, 2017 and became exercisable in three equal annual installments on February 17, 2018, February 17, 2019, February 17, 2020.

8. These options were granted on March 6, 2018 and become exercisable in three equal annual installments. The first and second installments became exercisable on March 6, 2019 and March 6, 2020, respectively. The third installment will become exercisable on March 6, 2021.

9. These options were granted on March 5, 2019 and become exercisable in three equal annual installments. The first installment became exercisable on March 5, 2020. The second and third installments will become exercisable on March 5, 2021 and March 5, 2022, respectively.

10. These options were granted on February 7, 2020 and will become exercisable in three equal annual installments on February 7, 2021, February 7, 2022, February 7, 2023.

Remarks:

	Julie D. Powell, Attorney-in-fact	08/03/2020
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.